Angiodynamics (ANGO) Non Operating Interest Expenses (2010 - 2024)

Angiodynamics (ANGO) has reported Non Operating Interest Expenses for 15 consecutive years, with -$567000.0 the latest figure, recorded in Q2 2024.

• For the quarter ending Q2 2024, Non Operating Interest Expenses fell 162.93% year-over-year to -$567000.0; the trailing twelve-month figure through May 2024 stood at -$1.6 million (down 159.73% YoY), and the FY2024 full-year result was -$1.6 million, down 159.73% from the prior year.
• Non Operating Interest Expenses declined to -$567000.0 in Q2 2024 per ANGO's latest filing, from -$394000.0 in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $901000.0 in Q2 2023 and bottomed at -$567000.0 in Q2 2024.
• Historically, Non Operating Interest Expenses has averaged $168777.8 across 5 years, with a median of $185000.0 in 2021.
• The sharpest annual moves came in 2020 and 2023: Non Operating Interest Expenses soared 473.17% in 2020, then slumped 178.07% in 2023.
• Over 5 years, Non Operating Interest Expenses stood at $235000.0 in 2020, then declined by 25.96% to $174000.0 in 2021, then surged by 293.1% to $684000.0 in 2022, then plunged by 178.07% to -$534000.0 in 2023, then slipped by 6.18% to -$567000.0 in 2024.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered -$567000.0, -$394000.0, and -$534000.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.